OLUGBENGA AJE: Open Payments
NPI 1104011774 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 18 payments from 9 companies in 2025. Trend: 2023 $363 · 2024 $783 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $198 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Alkermes, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Corium, LLC | 3 | $35 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: INVEGA SUSTENNA, REXULTI, SPRAVATO, ARISTADA, CAPLYTA, Azstarys, Auvelity, LYBALVI.
Industry payments across FL — which companies pay providers there.
